2024-02-282025-02-282025-02-28false15528010OROS CLINIC LTD2025-10-0386900falseiso4217:GBPxbrli:pure155280102024-02-27155280102025-02-28155280102024-02-282025-02-28155280102024-02-26155280102024-02-27155280102024-02-272024-02-2715528010bus:SmallEntities2024-02-282025-02-2815528010bus:AuditExempt-NoAccountantsReport2024-02-282025-02-2815528010bus:AbridgedAccounts2024-02-282025-02-2815528010bus:PrivateLimitedCompanyLtd2024-02-282025-02-2815528010core:WithinOneYear2025-02-2815528010core:AfterOneYear2025-02-2815528010core:WithinOneYear2024-02-2715528010core:AfterOneYear2024-02-2715528010core:ShareCapital2025-02-2815528010core:SharePremium2025-02-2815528010core:RevaluationReserve2025-02-2815528010core:OtherReservesSubtotal2025-02-2815528010core:RetainedEarningsAccumulatedLosses2025-02-2815528010core:ShareCapital2024-02-2715528010core:SharePremium2024-02-2715528010core:RevaluationReserve2024-02-2715528010core:OtherReservesSubtotal2024-02-2715528010core:RetainedEarningsAccumulatedLosses2024-02-2715528010core:LandBuildings2025-02-2815528010core:PlantMachinery2025-02-2815528010core:Vehicles2025-02-2815528010core:FurnitureFittings2025-02-2815528010core:OfficeEquipment2025-02-2815528010core:NetGoodwill2025-02-2815528010core:IntangibleAssetsOtherThanGoodwill2025-02-2815528010core:ListedExchangeTraded2025-02-2815528010core:UnlistedNon-exchangeTraded2025-02-2815528010core:LandBuildings2024-02-2715528010core:PlantMachinery2024-02-2715528010core:Vehicles2024-02-2715528010core:FurnitureFittings2024-02-2715528010core:OfficeEquipment2024-02-2715528010core:NetGoodwill2024-02-2715528010core:IntangibleAssetsOtherThanGoodwill2024-02-2715528010core:ListedExchangeTraded2024-02-2715528010core:UnlistedNon-exchangeTraded2024-02-2715528010core:LandBuildings2024-02-282025-02-2815528010core:PlantMachinery2024-02-282025-02-2815528010core:Vehicles2024-02-282025-02-2815528010core:FurnitureFittings2024-02-282025-02-2815528010core:OfficeEquipment2024-02-282025-02-2815528010core:NetGoodwill2024-02-282025-02-2815528010core:IntangibleAssetsOtherThanGoodwill2024-02-282025-02-2815528010core:ListedExchangeTraded2024-02-282025-02-2815528010core:UnlistedNon-exchangeTraded2024-02-282025-02-2815528010core:MoreThanFiveYears2024-02-282025-02-2815528010core:Non-currentFinancialInstruments2025-02-2815528010core:Non-currentFinancialInstruments2024-02-2715528010dpl:CostSales2024-02-282025-02-2815528010dpl:DistributionCosts2024-02-282025-02-2815528010core:LandBuildings2024-02-282025-02-2815528010core:PlantMachinery2024-02-282025-02-2815528010core:Vehicles2024-02-282025-02-2815528010core:FurnitureFittings2024-02-282025-02-2815528010core:OfficeEquipment2024-02-282025-02-2815528010dpl:AdministrativeExpenses2024-02-282025-02-2815528010core:NetGoodwill2024-02-282025-02-2815528010core:IntangibleAssetsOtherThanGoodwill2024-02-282025-02-2815528010dpl:GroupUndertakings2024-02-282025-02-2815528010dpl:ParticipatingInterests2024-02-282025-02-2815528010dpl:GroupUndertakingscore:ListedExchangeTraded2024-02-282025-02-2815528010core:ListedExchangeTraded2024-02-282025-02-2815528010dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-02-282025-02-2815528010core:UnlistedNon-exchangeTraded2024-02-282025-02-2815528010dpl:CostSales2024-02-272024-02-2715528010dpl:DistributionCosts2024-02-272024-02-2715528010core:LandBuildings2024-02-272024-02-2715528010core:PlantMachinery2024-02-272024-02-2715528010core:Vehicles2024-02-272024-02-2715528010core:FurnitureFittings2024-02-272024-02-2715528010core:OfficeEquipment2024-02-272024-02-2715528010dpl:AdministrativeExpenses2024-02-272024-02-2715528010core:NetGoodwill2024-02-272024-02-2715528010core:IntangibleAssetsOtherThanGoodwill2024-02-272024-02-2715528010dpl:GroupUndertakings2024-02-272024-02-2715528010dpl:ParticipatingInterests2024-02-272024-02-2715528010dpl:GroupUndertakingscore:ListedExchangeTraded2024-02-272024-02-2715528010core:ListedExchangeTraded2024-02-272024-02-2715528010dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-02-272024-02-2715528010core:UnlistedNon-exchangeTraded2024-02-272024-02-2715528010core:NetGoodwill2025-02-2815528010core:IntangibleAssetsOtherThanGoodwill2025-02-2815528010core:LandBuildings2025-02-2815528010core:PlantMachinery2025-02-2815528010core:Vehicles2025-02-2815528010core:FurnitureFittings2025-02-2815528010core:OfficeEquipment2025-02-2815528010core:AfterOneYear2025-02-2815528010core:WithinOneYear2025-02-2815528010core:ListedExchangeTraded2025-02-2815528010core:UnlistedNon-exchangeTraded2025-02-2815528010core:ShareCapital2025-02-2815528010core:SharePremium2025-02-2815528010core:RevaluationReserve2025-02-2815528010core:OtherReservesSubtotal2025-02-2815528010core:RetainedEarningsAccumulatedLosses2025-02-2815528010core:NetGoodwill2024-02-2715528010core:IntangibleAssetsOtherThanGoodwill2024-02-2715528010core:LandBuildings2024-02-2715528010core:PlantMachinery2024-02-2715528010core:Vehicles2024-02-2715528010core:FurnitureFittings2024-02-2715528010core:OfficeEquipment2024-02-2715528010core:AfterOneYear2024-02-2715528010core:WithinOneYear2024-02-2715528010core:ListedExchangeTraded2024-02-2715528010core:UnlistedNon-exchangeTraded2024-02-2715528010core:ShareCapital2024-02-2715528010core:SharePremium2024-02-2715528010core:RevaluationReserve2024-02-2715528010core:OtherReservesSubtotal2024-02-2715528010core:RetainedEarningsAccumulatedLosses2024-02-2715528010core:NetGoodwill2024-02-2615528010core:IntangibleAssetsOtherThanGoodwill2024-02-2615528010core:LandBuildings2024-02-2615528010core:PlantMachinery2024-02-2615528010core:Vehicles2024-02-2615528010core:FurnitureFittings2024-02-2615528010core:OfficeEquipment2024-02-2615528010core:AfterOneYear2024-02-2615528010core:WithinOneYear2024-02-2615528010core:ListedExchangeTraded2024-02-2615528010core:UnlistedNon-exchangeTraded2024-02-2615528010core:ShareCapital2024-02-2615528010core:SharePremium2024-02-2615528010core:RevaluationReserve2024-02-2615528010core:OtherReservesSubtotal2024-02-2615528010core:RetainedEarningsAccumulatedLosses2024-02-2615528010core:AfterOneYear2024-02-282025-02-2815528010core:WithinOneYear2024-02-282025-02-2815528010core:Non-currentFinancialInstrumentscore:CostValuation2024-02-282025-02-2815528010core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-282025-02-2815528010core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-282025-02-2815528010core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-282025-02-2815528010core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-282025-02-2815528010core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-282025-02-2815528010core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-282025-02-2815528010core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-282025-02-2815528010core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-282025-02-2815528010core:Non-currentFinancialInstrumentscore:CostValuation2025-02-2815528010core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-02-2815528010core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-02-2815528010core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-02-2815528010core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-02-2815528010core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-02-2815528010core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-02-2815528010core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-02-2815528010core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-02-2815528010core:Non-currentFinancialInstrumentscore:CostValuation2024-02-2715528010core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-2715528010core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-2715528010core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-2715528010core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-2715528010core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-2715528010core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-2715528010core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-2715528010core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-2715528010bus:Director12024-02-282025-02-2815528010bus:Director22024-02-282025-02-28

OROS CLINIC LTD

Registered Number
15528010
(England and Wales)

Unaudited Financial Statements for the Period ended
28 February 2025

OROS CLINIC LTD
Company Information
for the period from 28 February 2024 to 28 February 2025

Directors

Maria Antypa
Calin Hopsitar

Registered Address

7 Bell Yard
London
WC2A 2JR

Registered Number

15528010 (England and Wales)
OROS CLINIC LTD
Balance Sheet as at
28 February 2025

Notes

2025

£

£

Current assets
Debtors2
2
Creditors amounts falling due within one year(414)
Net current assets (liabilities)(412)
Total assets less current liabilities(412)
Net assets(412)
Capital and reserves
Called up share capital2
Profit and loss account(414)
Shareholders' funds(412)
The financial statements were approved and authorised for issue by the Board of Directors on 3 October 2025, and are signed on its behalf by:
Calin Hopsitar
Director
Maria Antypa
Director

Registered Company No. 15528010
OROS CLINIC LTD
Notes to the Financial Statements
for the period ended 28 February 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
2.Average number of employees

2025
Average number of employees during the year0